KRMDRepro Med Systems, Inc.

3.210USD-3.31%Mkt Cap: 148.21M $P/E:

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the F…

HeadlineSourceTime
Older
KORU (KRMD) Q2 2026 Earnings Call Transcript

Record quarterly revenue and first profitable quarter since 2019 signal momentum.

Motley Fool
KORU Medical Systems Inc (KRMD) (Q2 2026) Earnings Call Highlights: Record Revenue and First ...

Company achieves 18% revenue growth and raises gross margin guidance despite international headwinds and FESGO withdrawal.

GuruFocus.com
KORU Medical Systems Q2 Earnings Call Highlights

KORU Medical Systems (NASDAQ:KRMD) reported second-quarter revenue of $12 million, up 18% from a year earlier, as domestic patient starts, market-share gains and international demand supported growth. The company also said it achieved positive net income for the first time since 2019 and raised its

MarketBeat
KORU Medical Systems, Inc. Q2 2026 Earnings Call Summary

Moby summary of KORU Medical Systems, Inc.'s Q2 2026 earnings call

Moby
KORU Medical Systems, Inc. (KRMD) Q2 Earnings and Revenues Beat Estimates

KORU Medical Systems, Inc. (KRMD) delivered earnings and revenue surprises of +150.00% and +2.78%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks